Shalby has informed that the Company’s Wholly-owned Subsidiary Mars Medical Devices (MMDL) has further subscribed 2,00,000 equity shares of SGD 1 each in MMDL’S Subsidiary - Shalby Global Technologies, Singapore (SGTPL), and remitted funds for the same on December 1, 2022.
The above information is a part of company’s filings submitted to BSE.